Novo Nordisk Investigational Site

Alexandria, Virginia 22304

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Diabetes, Diabetes Mellitus, Type 2, End-Stage Renal Disease

Studies at this site

• Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early